Many EU HTA Bodies Wary Of Involvement In 'ADAPT SMART' MAPPs Project
This article was originally published in SRA
Efforts are being made to involve more health technology assessment (HTA) bodies in the ADAPT SMART initiative, which is intended to coordinate Medicines Adaptive Pathways to Patients (MAPPs) activities in Europe. However, many HTAs are reluctant to take part, partly because of resource issues and partly because they do not want to invest public funding in projects involving private companies.
You may also be interested in...
A project is about to begin to understand the factors that influence marketing decisions in the various EU member states.
EU trade expert Hervé Jouanjean considers the reasoning behind the EU’s vaccine procurement approach and Italy's decision to block exports of AstraZeneca's COVID-19 vaccine.
Coronavirus Notebook: Italy Makes First Use Of EU’s Vaccine Export Control System, More Regulators Issue Guidance On Variants
Ukraine has established a system for issuing emergency use authorizations for COVID-19 vaccines that recognizes authorizations granted by other world regulators.